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Amikacin  is an  important  antibiotic,  and  its  use  is  limited  because  of the  induced  nephrotoxicity.  Thus,
search  for  natural  and  synthetic  agents  that can moderate  amikacin  toxicity  never  stopped.  The  present
study  aims  to  investigate  the  possible  ameliorative  effects  of virgin  olive  oil  and  olive  leaf extract  against
the  amikacin-induced  nephrotoxicity  in rat.
Methods: 48  rats  were  distributed  into  6 groups:  1-Animals  of  control  (C) group  were  injected  intraperi-
toneally  (ip) with  saline,  2-(AK);  injected  ip  with  amikacin  {300  mg/kg/day  for  12days},  3-(OO)  group:
given  olive  oil  {7  ml/kg/day  for 16days},  4-(OOAK)  group:  given  olive  oil as  in OO  and  amikacin  for  12days,
5-(OL)  group:  given  olive  leaf  extract  {50  mg/kg/day  for 16days},  6-(OLAK)  group:  given leaf  extract  as  in
OL and  amikacin  for 12days.  Animals  were  fasted  and  sacriﬁced.  Serum  was  used for  biochemical  analysis
and  kidneys  for histopathology.
Results:  Serum  urea  and  creatinine  were  signiﬁcantly  (P < 0.001)  elevated  in  AK,  and  signiﬁcantly  dropped
in the  OOAK  and  OLAK  groups.  Serum  uric  acid  was  reduced  in AK  by 45.29%.  Kidneys  from  AK  showed
necrosis,  whereas,  those  from  OOAK  and  OLAK  showed  mild  histology.  The  serum  triglyceride  was
decreased  by  17.8%  in  OL, by 37.02%  in OOAK  and  by  31.48%  in  OLAK.  The  calculated  amikacin  effect
showed  a signiﬁcant  positive  correlation  with  urea  (r  = 0.521,  P = 0.0004),  and  a  negative  correlation  with
uric  acid  (r  =  −  0.58,  P < 0.0001).
Conclusion:  The  study  conﬁrmed  nephrotoxicity  of amikacin  in rat which  was  ameliorated  by  virgin  olive
oil  and by  olive  leaf  extract.  Amikacin  did not  cause  dyslipidemia  but  reduced  serum  uric  acid.
© 2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
A wide variety of drugs and pesticides are known to induce
enal toxicity in human and experimental animals. It has been
eported that about 27% of acute kidney diseases in the United
tates are caused by usage of drugs [29]. Among these nephrotoxic
rugs are cisplatin, oxytetracycline and cyclosporine [27,1,19]. Pes-
icides that kill insects by targeting their nervous system such as
rganophosphates and the carbamates are also known to induce
ephrotoxicity [18,17]. The aminoglycosides, a group of related
ntibiotics, are known to generate reactive oxygen species (ROS)
Abbreviations: AK, amikacin; OO, olive oil; OL, olive leaf; TG, triglyceride;
DL, low density lipoprotein; VLDL, very low density lipoprotein; EAE, estimated
mikacin effect.
∗ Corresponding author.
E-mail address: aabdelgayoum@hotmail.com (A.A. Abdel-Gayoum).
ttp://dx.doi.org/10.1016/j.toxrep.2015.09.007
214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
which may  cause a wide range of kidney related complications that
include acute and chronic renal failure [5] and secondary hyper-
lipidemia [27,2]. Amikacin (AK) is an aminoglycoside antibiotic
commonly used for the treatment of a wide spectrum of gram-
negative bacterial infections. Like other nephrotoxic drugs, the
clinical use of AK is limited because of its development of nephro-
toxicity [28]. The nephrotoxic side effects of AK, characterized by
tubular necrosis, have been documented in experimental animals
[22] and in humans [28]. As in many aminoglycosides, the mecha-
nism underlying AK toxicity is believed to be its ability to generate
ROS [15]. ROS are known to mediate cascade processes leading
to tissue damage in the kidney tubules. Several plant polyphe-
nols, known to have antioxidant activity, have shown ameliorative
effects on the AK induced nephrotoxicity [31], cisplatin nephrotox-
icity [4] and oxytetracycline toxicity [1].
Virgin olive oil and more recently, the olive leaves were shown
to be rich in antioxidant polyphenols such as oleuropein, verbasco-
side, ligstroside, tyrosol and hydroxytyrosol [11]. Olive leaf extracts
 article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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re now marketed as anti-aging, immunostimulant, antioxidant,
nti-inﬂammatory and antimicrobial agents. Tavaﬁ et al. [30]
emonstrated that the use of olive leaf- extract can protect against
entamicin nephrotoxicity. In this study, we aimed to evaluate
he protective effects of virgin olive oil and the ethanol extract
f olive leaf against amikacin-induced nephrotoxicity in the rat.
ince several nephrotoxic drugs are known to induce secondary
yslipidemia [2], beside assessing the kidney function parameters
e measured the serum total cholesterol and triglyceride concen-
rations. To our knowledge, this is the ﬁrst study to investigate
he efﬁciency of olive leaf extract in the modulation of amikacin
ephrotoxicity in experimental animals.
. Materials and methods
.1. Materials
Green olive leaves were picked from olive trees at Al-Zaitona
ark, Hail, Saudi Arabia. 200 g of the air dried olive leaves were
round into ﬁne powder. The nephrotoxic dose of amikacin was
alculated according to Houghton et al. [13] and the olive leaf
xtract was prepared and dose calculated according to the method
escribed by Tavaﬁ et al. [30]. Brieﬂy, the powder was  extracted
wice with 1 L of 80% (v/v) ethanol. The extract was  ﬁltered using
 cotton mesh and the solvent of the pooled extract was evapo-
ated under vacuum using rotary evaporator till dryness. The dry
xtract was stored refrigerated at 4 ◦C till use within two  weeks.
resh virgin olive oil was purchased from the local Hail market.
njectable amikacin (miacin) was obtained from Hikma Pharma-
euticals, Amman, Jordan.
Male Albino rats weighing 167.40 ± 26.34 g (150–210 g) were
btained from the Animal House-King Saud University, Riyadh,
SA, and placed in a temperature (21 ± 2 ◦C) and humidity (60 ± 5%)
ontrolled room in which a 12:12 h light:dark cycle was  main-
ained. The animals had free access to a nutritionally adequate
tandard pelleted diet and tap water.
.2. Protocol of experiment
Forty eight rats were distributed randomly into six groups (eight
ats in each): 1-Control Group {C}; Animals of this group were
njected intraperitoneally (ip) with saline daily for 12 days. 2-
mikacin Group {AK}: Animals were injected ip with amikacin
miacin) (300 mg/kg/d for 12 days). 3-Olive Oil Group {OO}: Ani-
als of this group were given by gastric intubation olive oil
7 ml/kg/day for 16 days). 4-Olive Oil and Amikacin Group {OOAK}:
he animals were fed with olive oil (7 ml/kg/day for 16 days), from
ay 4 the animals were injected ip with amikacin (300 mg/kg/d for
2 days). 5-Olive Leaf Extract Group {OL}: The animals were fed by
astric intubation weighed amounts of olive leaf extract dissolved
n distilled water at a dose of 50 mg/kg/day for 16 days. 6- Olive
eaf Extract and Amikacin Group {OLAK}: Animals of this group
ere fed with olive leaf extract (50 mg/kg/day for 16 days), from
ay 4 the animals were treated ip with amikacin (300 mg/kg/day for
2 days). At the end of treatments, all rats were fasted overnight
nd sacriﬁced by cervical decapitation. Blood was collected from
he trunk into plain tubes and serum was separated by centrifuga-
ion at 2000 × g for 10 min  at 5 ◦C. The left kidney of each rat was
xcised rapidly and kept in 10% formal- saline at 24 ◦C for routine
istopathological examination by light microscopy.
.3. Biochemical assaysSerum creatinine, urea, uric acid, triglyceride (TG) and total
holesterol were assayed spectrophotometrically using commer-
ial kits from BioMerieux-France. Reports 2 (2015) 1327–1333
2.4. Histological examination
The kidneys were removed from formalin and embedded in
parafﬁn wax. The parafﬁn-embedded blocks were cut into 4–5 m
slices and stained with hematoxylin and eosin. Five slides were ran-
domly selected from each group and were examined under light
microscope by a histopathologist unaware of the treatments. The
intensity of the tubular injury was assessed as described by Celik
et al. [7] with slight modiﬁcation as follows:
Score Stage of tubular injury
0  (Normal) No necrosis
I  (Mild) usually single cell necrosis in scarce tubules
II  (Moderate) more than one cell involved in sparse tubules
III (Marked) tubules exhibiting total necrosis in almost every power ﬁeld
All experimental procedures were carried out in accordance to
the Helsinki declaration for animal experiments and approved by
the
Research Ethical Committee, Faculty of Applied Medical Sci-
ences, University of Hail.
2.5. Calculation of estimated amikacin effect (EAE)
This was extracted from the ratio between the serum creatinine
concentration (umol/L) in each rat and the amount of amikacin
injected to the rat. The EAE in each rat was  calculated according
to the following equation: EAE = (serum creatinine (umol/L)/(total
amount of amikacin given in 12 days) × 100. (Zero value of EAE was
given to animals not treated with the drug).
2.6. Statistical analysis
The presented data are means ± SD. The differences between
the means were computed by ANOVA using Statistical Package
for Social Sciences version 16.0 (SPSS Inc., Chicago, IL, USA). The
signiﬁcance of differences between the means was carried out by
Unpaired Student‘s T-test. p values <0.05 were considered signif-
icant. The regression analysis between the EAE (as independent
variable) and various dependent parameters was carried out by
Spearman‘s Regression analysis. p values <0.05 were considered
signiﬁcant.
3. Results
3.1. The kidney function parameters
The serum creatinine concentration was signiﬁcantly elevated
in the amikacin-alone treated group by 34.6%, whereas, it showed
a signiﬁcant drop by 33.3% in the OO group compared with control
(Table 1). However, the OOAK group showed serum creatinine con-
centration not signiﬁcantly different from that of the OO animals.
On the other hand, the OL group had their serum creatinine levels
signiﬁcantly lower than control by 16%, whereas, the OLAK animals
had the serum creatinine level lower by 36.63% from the amikacin-
alone treated group and not different from those treated with olive
leaf extract.
Similarly, the serum urea concentration was signiﬁcantly ele-
vated in the group treated with amikacin by 59.15%, whereas, the
OOAK group showed a drop in their serum urea concentration by
43.89% compared to the AK group. However, the serum urea con-
centration in animals of OLAK group showed a signiﬁcant decrease
by 46.85% compared to the amikacin-alone treated group.
In contrast, the serum uric acid concentrations were signiﬁ-
cantly decreased in the AK, OOAK and the OLAK groups by 45.29%,
42.20% and 32.94%, respectively compared to control. However,
the OLAK group exhibited a drop in the uric acid level by 20.83%
compared to the OL group.
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Table  1
The kidney function parameters and serum total lipids in (C) control, (AK) amikacin treated,(OO) olive oil-treated, (OOAK) co-treated with olive oil and amikacin, (OL) olive
leaf  extract treated and (OLAK) co-treated with olive-leaf extract and amikacin groups. The presented data are mean ± SD. * P < 0.05, †  P < 0.01, ‡  P < 0.001.a: signiﬁcantly
different  from C, b: signiﬁcantly different from AK, c: signiﬁcantly different from OO, d: signiﬁcantly different from OOAK, e: signiﬁcantly different from OL.
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Interestingly, the serum TG level was signiﬁcantly decreased in
he OL animals by 17.8% compared to controls. Moreover, the serum
G concentrations in the OOAK and OLAK groups were dropped by
7.02 %, and 31.48%, respectively compared to control. However,
he serum total cholesterol was not signiﬁcantly altered in the ani-
als of AK, OO or OOAK, whereas, it was decreased in the OL group
ompared to control.
.3. Changes in kidney histology
As shown in Fig. 1, the kidney sections from control, OO and OL
roups revealed apparently normal tubules (Grade 0). However,
ections of the kidneys from AK group showed marked tubular
ecrosis (Grade III). On the other hand, the sections of cortices
rom OOAK and OLAK groups showed moderate (Grade II) and mild
Grade I) appearances, respectively.
.4. Regression analysis
Table 2 and Fig. 3 summarize the correlation between the EAE
nd the serum urea, uric acid and serum total lipids. Signiﬁcant
ositive corelations were observed between the amikacin effect
nd serum creatinine and urea (r = 0.484. P = 0.001 and r = 0.521,
 = 0.0004, respectively). On the other hand, a signiﬁcant negative
orrelation was evident between the amikacin effect and serum uric
cid (r = − 0.58, P < 0.0001). Similarly, a slight negative correlation
as shown between the amikacin effect and serum TG (r = − 0.28,
 = 0.051). However, no signiﬁcant correlation was  shown between
he drug effect and serum cholesterol.
. Discussion
Amikacin is one of the most commonly prescribed antibiotics
or the treatment of Gram negative infections. The most accepted
echanism of action underlying the pathogenesis of its nephro-
oxicity is the ability of the drug and its metabolites to generate
xygen free radicals [15,21]. This has guided the investigators
o search for suitable potent antioxidants as protective agents
gainst its induced nephrotoxicity. Olive oil is believed to be rich
n polyphenols and has been tried as a protective agent against
ome nephrotoxic drugs [24]. Recently, olive leaves were reportedto be rich in polyphenols [30] and have shown antioxidant and anti-
inﬂammatory activity [9]. While the availability of virgin olive oil is
seasonal, olive leaves can be freely picked throughout the year from
the numerous olive trees in Hail region. In the present study we
studied the effectiveness of olive leaf extract in protecting against
the amikacin nephrotoxicity compared to the olive oil. As expected,
rats treated with amikacin alone exhibited signiﬁcant elevation in
the serum levels of creatinine and urea, indicating severe nephro-
toxicity. This was  conﬁrmed by the severe degeneration of the
kidney cortical tissues of these animals. The nephrotoxicity of
amikacin, as other aminoglycosides, is well established and sev-
eral authors have used antioxidant agents to ameliorate its toxicity
[15,21]. However, treatment of the animals with olive oil prior to
their exposure to drug slightly ameliorated the kidney function and
cortical histology. The serum creatinine level was lower than the
amikacin-alone treated animals and they exhibited moderate alle-
viation of the kidney cortical injury. On the other hand, the animals
pretreated with olive-leaf extract prior to amikacin exposure had
their serum creatinine concentrations signiﬁcantly lower and their
kidney cortical injury signiﬁcantly ameliorated. Olive leaves are
rich in polyphenols and their extract was  used to protect against
gentamicin nephrotoxicity [30] and carbon tetrachloride toxicity
[6]. The reported polyphenols of olive, oleuropein, verbascoside
and ligstroside, are powerful antioxidants which can sequester the
generated drug induced oxygen free radicals in the kidney [14],
and inhibit the pro-oxidant lipoxygenase enzyme activity [16].
The ameliorative effect of olive leaf extract against the amikacin
nephrotoxicity was comparable or better than that of the virgin
olive oil. The serum creatinine in the animals treated with both
oil and drug was  still higher than that treated with the olive oil
alone, whereas, those exposed to leaf extract with the drug had
their creatinine not different from those fed with leaf extract alone.
Interestingly however, amikacin treatment did not exhibit any
elevation in serum triglyceride or cholesterol levels. This was dif-
ferent from our previous ﬁndings with other nephrotoxic drugs,
where severe secondary dyslipidemia was observed in gentamicin-
induced nephrotoxicity [3], and in cisplatin nephrotoxicity [2].
In these nephrotoxic drugs the mechanism underlying the sec-
ondary dyslipidemia was  suggested to be increased cholesterol
synthesis caused by the accumulation of mevalonate, the substrate
and activator of HMG-CoA reductase. HMG-CoA reductase is the
regulatory enzyme for cholesterol biosynthesis. Accumulation of
mevalonate was  thought to be due to its decreased catabolism
1330 A.A. Abdel-Gayoum et al. / Toxicology Reports 2 (2015) 1327–1333
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Tig. 1. The histopathology of kidney cortices of rats; (C) control, (AK) amikacin treated, (O
xtract  treated and (OLAK) co-treated with olive leaf extract and amikacin groups. The sl
xtensive tubular necrosis in the AK group.
able 2
he regression analysis of the estimated amikacin effect (as independent variable) and thO) olive oil-treated, (OOAK) co-treated with olive oil and amikacin, (OL) olive leaf
ides were stained with hematoxylin and eosin. (×40 mm). The arrow indicates the
e kidney function parameters or serum lipids (as dependent variables).
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Fig. 2. Structures of hypoxanthine, the substrate of xanthine oxidase, allopurinol, co
ith  carbonyl and imino groups common in amikacin and in both substrate and they the kidney [10]. The secondary hypertriglyceridemia was sug-
ested to be due to reduction in the activity of lipoprotein lipase
nd hepatic lipase, the enzymes responsible for catabolism of the
irculating triglyceride-rich VLDL particles [25]. In gentamicin and
ig. 3. The plots of regression analysis between the estimated amikacin effect (as independtive inhibitor for xanthine oxidase and amikacin drug. The arrow shows the domain
entional enzyme inhibitor.cisplatin nephrotoxicity, the mechanism underlying their toxicity
and dyslipidemia was  related to the ability of these drugs and their
metabolites to accumulate in the kidney cortex [23,26]. This may
not be occurring with amikacin. However, further investigation is
ent variable) and the serum urea, uric acid and triglyceride (as dependent variables).
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equired to explain the exact cause of variation between amikacin
nd the other nephrotoxic drugs in their effects on lipid metabolism
nd regulation.
On the other hand, the olive leaf extract actively reduced the
erum cholesterol and triglyceride levels. It was shown that the
live polyphenols can protect the LDL particles from oxidation
8]. Oxidized LDL is not recognized by the LDL-receptors thus not
aken up by the cells leading to the elevation of circulating total
holesterol concentration. Moreover, the co-administration of both
mikacin and olive oil or leaf extract did not alter the observed
eduction in the serum triglyceride concentration. The fact that
reatment with amikacin does not cause secondary dyslipidemia
ives an advantage for amikacin as an antibiotic drug over the other
minoglycosides.
Another interesting ﬁnding in this study is the signiﬁcant reduc-
ion of the serum uric acid levels in the animals treated with
mikacin compared to the control. This was an unexpected obser-
ation since in kidney impairment the serum uric acid is elevated
ue to its delayed excretion. Uric acid is the excretory product
f purine catabolism, and the ﬁnal steps in uric acid biosynthesis
nvolves the oxidation of hypoxanthine into xanthine then further
xidation of xanthine into uric acid. The reactions are catalyzed by
anthine oxidase, a metallo- enzyme that contains molybdenum
nd iron [12]. In treatment of hyperurecemia allopurinol is the
rug of choice. Allopurinol structurally resembles hypoxanthine,
hus it competitively inhibits the xanthine oxidase enzyme. Allop-
rinol is hydroxylated by xanthine oxidase at the 2-position to give
xipurinol which consequently binds the reduced molybdenum ion
f the enzyme causing its inhibition [20]. Amikacin has an exposed
omain with a carbonyl group and an imino group which resembles
he hypoxanthine and allopurinol structure (Fig. 2). This makes it
ost appropriate to suggest that amikacin or some of its metabo-
ites may  impose an inhibitory effect on the enzyme responsible for
he synthesis of uric acid. To validate this theory we calculated the
orrelation of the estimated amikacin effect (calculated as a ratio
etween the serum creatinine concentration and the units of drug
iven to the animal) and the serum uric acid. As indicated in Table 2
nd Fig. 3, a signiﬁcant positive correlation was shown with creati-
ine, whereas, a highly signiﬁcant negative correlation was  evident
ith the uric acid. Moreover, a signiﬁcant negative correlation was
lso shown with the serum triglyceride, whereas, no correlation
as shown with serum cholesterol. This supports the suggestion
hat amikacin has a strong depressing effect on the serum uric acid
oncentration, and to a lower extent the serum TG level. Thus our
ndings indicate that the drug beside its antibiotic activity may  be a
otent candidate for the management of hyperurecemia and gout.
. Conclusion
The study conﬁrmed that amikacin at a dose 300 mg/kg/d for 12
ays induces nephrotoxicity in the rat. The drug toxicity was  ame-
iorated by the virgin olive oil and ethanol extract of olive leaves.
n contrast to gentamicin and cisplatin, the amikacin nephrotoxic-
ty did not induce dyslipidemia. Amikacin treatment depressed the
erum uric acid concentration, possibly by inhibition of the urate
iosynthesis. Further studies are needed to elucidate the mecha-
ism underlying the reducing effects of olive leaf extract on the
erum triglyceride and cholesterol concentrations.
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